Back
 APD  Vol.5 No.3 , August 2016
Contribution of Musculoskeletal Disorders to Chronic Lumbago in Parkinson’s Disease
Abstract: Purpose: To clarify the impact of bone metabolism disorder on lumbago in Parkinson’s Disease (PD). Methods: Data was retrospectively analyzed from 52 patients with PD in our outpatient clinic for more than 1 year (mean age, 63 ± 4 years old; mean duration from onset, 6.3 ± 0.8 years). Patients’ characteristics, comorbid musculoskeletal disorders, serum bone metabolism biomarkers, and bone mineral density were examined. Results: Twenty-one PD patients (40.2%) had chronic lumbago. Severe comptocormia and scoliosis were the most common musculosketal disorders in this group (47.6%) affected by lumbago, followed by osteoporosis (14.3%), compression fracture (4.8%). There was no significant difference in the duration of PD, body mass index, frequency of falls, bone mineral density, tartrate-resistant acid phosphatase-5b, osteocalcin, and N-terminal telopeptide between PD patients with or without chronic lumbago. Multivaritae logistic regression analysis identified the independent predictors of chroni lumbago in PD patients as Hoen-Yahr stage (odds ration [OR] = 2.794, 95%CI 1.103 - 7.076), and elevated serum 1,25-OH2 vitamin D level ([OR] = 0.92, 95%CI 0.86 - 98). Conclusion: Bone metabolism disorders are found to be associated with chronic lumbago in PD patients.
Cite this paper: Shiraishi, M. , Shinohara, K. , Akamatsu, M. and Hasegawa, Y. (2016) Contribution of Musculoskeletal Disorders to Chronic Lumbago in Parkinson’s Disease. Advances in Parkinson's Disease, 5, 61-66. doi: 10.4236/apd.2016.53008.
References

[1]   Chaudhuri, K.R., Healy, D.G. and Schapira, A.H. (2006) Non-Motor Symptoms of Parkinson’s Disease: Diagnosis and Management. Lancet Neurology, 5, 235-245. http://dx.doi.org/10.1016/S1474-4422(06)70373-8

[2]   Koller, W.C. (1984) Sensory Symptoms in Parkinson’s Disease. Neurology, 34, 957-959.
http://dx.doi.org/10.1212/WNL.34.7.957

[3]   Broetz, D., Eichner, M., Gasser, T., Weller, M. and Steinbach, J.P. (2007) Radicular and Nonradicular Back Pain in Parkinson’s Disease: A Controlled Study. Movement Disorders, 22, 853-856. http://dx.doi.org/10.1002/mds.21439

[4]   Defazio, G., Berardelli, A., Fabbrini, Ge., Martino, D., Fincati, E., Fiaschi, A., Moretto, G., Abbruzzese, G., Marchese, R., Bonuccelli, U., Del Dotto, P., Barone, P., De Vivo, E., Albanese, A., Antonini, A., Canesi, M., Lopiano, L., Zibetti, M., Nappi, G., Martignoni, E., Lamberti, P. and Tinazzi, M. (2008) Pain as a Nonmortor Symptom of Parkinson’s Disease. Archives of Neurology, 65, 1191-1194. http://dx.doi.org/10.1001/archneurol.2008.2

[5]   Négre-Pagés, L., Regragui, W., Bouhasssira, D., Grandjean, H., Rascol, O., and for DoPaMiP Study Group (2008) Chronic Pain in Parkinson’s Disease: the Cross-Sectional French DoPaMiP Survey. Movement Disorders, 23, 1361- 1369. http://dx.doi.org/10.1002/mds.22142

[6]   Khosla, S. and Riggs, B.L. (2005) Pathophysiology of Age-Related Bone Loss and Osteoporosis. Endocrinology and Metabolism Clinics of North America, 34, 1015-1030.
http://dx.doi.org/10.1016/j.ecl.2005.07.009

[7]   Genant, H.K., Wu, C.Y., van Kuijik, C. and Nevitt, M.C. (1993) Vertebral Fracture Assessment Using a Semi-Quan- titative Technique. Journal of Bone and Mineral Research, 8, 1137-1148.
http://dx.doi.org/10.1002/jbmr.5650080915

[8]   Karlsen, K.H., Tandberg, E., Arsland, D. and Larsen, J.P. (2000) Health Related Quality of Life in Parkinson’s Disease: A Prospective Longitudinal Study. Journal of Neurology, Neurosurgery & Psychiatry, 69, 584-589. http://dx.doi.org/10.1136/jnnp.69.5.584

[9]   Loge, J.H. and Kaasa, S. (1998) Short Form 36 (SF36) Health Survey: Normative Data from the General Norwegian Population. Scandinavian Journal of Social Medicine, 26, 250-259.

[10]   Lindvall, O., Bjorklund, A. and Skagerberg, G. (1983) Dopamine-Containing Neurons in the Spinal Cord: Anatomy and Some Functional Aspects. Annals of Neurology, 14, 255-260.
http://dx.doi.org/10.1002/ana.410140302

[11]   Mylius, V., Engau, I., Teepker, M., Stiasny-Kolster, K., Schepelmann, K., Oertel, W.H., Lautenbacher, S. and Moller, J.C. (2009) Pain Sensitivity and Descending Inhibition of Pain in Parkinson’s Disease. Journal of Neurology, Neurosurgery & Psychiatry, 80, 24-28.
http://dx.doi.org/10.1136/jnnp.2008.145995

[12]   Brefel-Courbon, C., Payoux, P., Tahlmas, C., Ory, F., Quelven, I., Chollet, F., Montastruc, J.L. and Rascol, O. (2005) Effect of Levodopa on Pain Threshold in Parkinson’s Disease: A Clinical and Positron Emission Tomography Study. Movement Disorders, 20, 1557-1563.
http://dx.doi.org/10.1002/mds.20629

[13]   Sato, Y., Iwamoto, J. and Honda, Y. (2011) Amelioration of Osteoporosis and Hypovitamininosis D by Sunlight Exposure in Parkinson’s Disease. Parkinsonism & Related Disorders, 17, 22-26. http://dx.doi.org/10.1016/j.parkreldis.2010.10.008

[14]   Holick, M.F. (2007) Vitamin D Deficiency. The New England Journal of Medicine, 357, 266-281. http://dx.doi.org/10.1056/NEJMra070553

[15]   Kamanli, A., Ardicoglu, O., Ozgocmen, S. and Yoldas, T.K. (2008) Bone Mineral Density in Patients with Parkinson’s Disease. Aging Clinical and Experimental Research, 20, 277-279.
http://dx.doi.org/10.1007/BF03324774

[16]   Lam, K., Li, M., Mok, V., Hui, A. and Woo, J. (2010) A Case Control Study on Bone Mineral Density in Chinese Patients with Parkinson’s Disease. Parkinsonism & Related Disorders, 16, 471-474. http://dx.doi.org/10.1016/j.parkreldis.2010.05.002

[17]   Taggart, H. and Crawford, V. (1995) Reduced Bone Density of the Hip in Elderly Patients with Parkinson’s Disease. Age and Ageing, 24, 326-328. http://dx.doi.org/10.1093/ageing/24.4.326

[18]   Lorefalt, B., Toss, G. and Granérus, A.K. (2007) Bone Mass in Elderly Patients with Parkinson’s Disease. Acta Neurologica Scandinavica, 116, 248-254.
http://dx.doi.org/10.1111/j.1600-0404.2007.00875.x

[19]   Abou-Raya, S., Helmii, M. and Abou-Raya, A. (2009) Bone and Mineral Metabolism in Older Adults with Parkinson’s Disease. Age and Ageing, 38, 675-680. http://dx.doi.org/10.1093/ageing/afp137

[20]   Bezza, A., Ouzzif, Z., Naji, H., Achemlal, L., Mounach, A., Nouijai, M., Bourazza, R., Mossadeq, A. and Maghraoui, E.I. (2008) Prevalence and Risk Factors of Osteoporosis in Patients with Parkinson’s Disease. Rheumatology International, 28, 1205-1209. http://dx.doi.org/10.1007/s00296-008-0632-6

[21]   Sato, Y., Kaji, M., Tsuru, T., Satoh, K. and Kondo, I. (2002) Vitamin K Deficiency and Osteopenia in Vitamin D-De- ficient Elderly Women with Parkinson’s Disease. Archives of Physical Medicine and Rehabilitation, 83, 86-91. http://dx.doi.org/10.1053/apmr.2002.27376

 
 
Top